Q8VDG7
Gene name |
Pafah2 |
Protein name |
Platelet-activating factor acetylhydrolase 2, cytoplasmic |
Names |
PAF:lysophospholipid transacetylase, PAF:sphingosine transacetylase, Platelet-activating factor acetyltransferase PAFAH2, Serine-dependent phospholipase A2, SD-PLA2 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:100163 |
EC number |
2.3.1.149: Transferring groups other than amino-acyl groups |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8VDG7
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8VDG7-F1 | Predicted | AlphaFoldDB |
26 variants for Q8VDG7
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388706069 | 104 | I>S | No | EVA | |
| rs3388714650 | 120 | C>Y | No | EVA | |
| rs3395032130 | 126 | R>C | No | EVA | |
| rs254774812 | 156 | A>T | No | EVA | |
| rs3388717643 | 203 | G>R | No | EVA | |
| rs227379060 | 223 | I>V | No | EVA | |
| rs239632579 | 225 | R>T | No | EVA | |
| rs263409397 | 226 | N>S | No | EVA | |
| rs3388720501 | 229 | A>S | No | EVA | |
| rs3388721225 | 243 | A>D | No | EVA | |
| rs3388726272 | 244 | L>M | No | EVA | |
| rs3388720146 | 247 | E>K | No | EVA | |
| rs3388716203 | 248 | V>D | No | EVA | |
| rs3388726291 | 249 | Q>K | No | EVA | |
| rs3388719167 | 270 | K>E | No | EVA | |
| rs3388717570 | 272 | R>W | No | EVA | |
| rs3388719161 | 277 | F>V | No | EVA | |
| rs3388714295 | 284 | Q>R | No | EVA | |
| rs239685044 | 289 | V>I | No | EVA | |
| rs3388719116 | 290 | N>K | No | EVA | |
| rs1134901660 | 300 | E>G | No | EVA | |
| rs3388724178 | 332 | S>R | No | EVA | |
| rs234660596 | 351 | I>M | No | EVA | |
| rs3388724247 | 359 | L>R | No | EVA | |
| rs3388721186 | 369 | S>N | No | EVA | |
| rs3388697194 | 377 | P>T | No | EVA |
No associated diseases with Q8VDG7
No regional properties for Q8VDG7
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q8VDG7 | |||
Functions
| Description | ||
|---|---|---|
| EC Number | 2.3.1.149 | Transferring groups other than amino-acyl groups |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| 1-alkyl-2-acetylglycerophosphocholine esterase activity | Catalysis of the reaction: 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine + H2O = 1-alkyl-sn-glycero-3-phosphocholine + acetate. |
| platelet-activating factor acetyltransferase activity | Catalysis of the reaction: 1-radyl-2-acyl-sn-glycero-3-phospholipid + 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine = 1-alkyl-2-lyso-sn-glycero-3-phosphocholine + 1-radyl-2-acetyl-sn-glycero-3-phospholipid. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| lipid catabolic process | The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
| negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGAGQSVCFP | PISGPHHIGC | TDVMEGHSLE | GSLFRLFYPC | QASEKCEQPL | WIPRYEYSMG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LADYLQYNKR | WVGLLFNVGI | GSCRLPVSWN | GPFKAKESGY | PLIILSHGLG | GFRASYSAFC |
| 130 | 140 | 150 | 160 | 170 | 180 |
| MELASRGFVV | AAVEHRDQSA | AATYFCKPTS | QESSPAESLE | EEWLPFRRIK | EGEKEFHVRN |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PQVHQRVKEC | VRVLRILQDA | SAGKTVVNVF | PGGLDLMTLK | GSIDRNRVAV | MGHSFGGATA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VLALTQEVQF | RCAIALDAWM | FPLERDFYPK | ARGPVFFINV | EKFQTVESVN | LMKKICAQHE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| QSRIVTVLGA | VHRSQTDFAF | VTGNLIAKFF | SSNSRGTLDP | YESQEVMVRA | ILAFLQKHLD |
| 370 | 380 | ||||
| LKEDYDQWSS | FIEGVGPSLI | QGAPHYLSSL |